BabyOrgano Secures Rs 20 Crore to Boost Ayurvedic Kids' Wellness Range
- BabyOrgano has raised Rs 20 crore in a pre-Series A funding round, led by RPSG Capital Ventures with support from existing investor Sauce.vc.
- The company is targeting an ambitious Rs 100 crore revenue milestone by the end of FY27, driven by strategic growth initiatives.
- With fresh capital, BabyOrgano will focus on launching new products, expanding distribution channels, and strengthening its brand visibility across India.
BabyOrgano, a startup offering Ayurveda-based wellness products for children, has raised Rs 20 crore ($2.4 million) in a pre-Series A funding round. The investment was led by RPSG Capital Ventures, with existing investor Sauce.vc also participating.
Launched in 2020 by husband-wife duo Riddhi and Ripul Sharma, BabyOrgano focuses on over-the-counter Ayurvedic remedies targeted at everyday health needs of children. The brand has gained a customer base of over one million parents and reports a repeat purchase rate of more than 40%.
The company will use the fresh capital to strengthen product development, marketing initiatives, and operational scaling. BabyOrgano is eyeing Rs 100 crore in revenue by the fiscal year 2027.
Currently, the company offers products such as Baalprashan Swarnaprashan Drops, Cold Relief Roll-On, Cough Syrup, Sitopaladi Churna, Chocovita Milk Mix, and Ayurvedic gummies. These are available across e-commerce platforms and retail outlets.
Also Read: MedySeva Secures Rs 4 Crore to Expand Rural Healthcare Network
With this funding, BabyOrgano plans to enhance its R&D capabilities, widen its distribution network, and build deeper brand reach across India. It will also invest in supply chain optimization to support future growth.
BabyOrgano competes in the growing kids' Ayurvedic care segment alongside brands like Mamaearth, The Moms Co., Mother Sparsh, Dabur, Himalaya BabyCare, and Kapiva Kids.
